Balance System Study in Type 2 Diabetic Patients

Inclusion Criteria: * Type 2 Diabetes inadequately controlled on a maximum of three oral anti-diabetic agents * HbA1c between 7 and 10% inclusive * Fasting Blood Glucose between 126 and 200 mg/dL * Body Mass Index (BMI) in the range of 30.0 to 45.0 kg/m2 * Stable oral anti-diabetic therapy for at least 3 months * Subjects who are able and willing to perform self monitoring of plasma glucose for the entire trial period * Able and willing to sign informed consent and return for follow-up assessments Exclusion Criteria: * Type 1 Diabetes * Subjects at high risk of general anesthesia or surgery * Subjects with prior pancreatitis * Subjects treated with insulin within three months of screening * Female with a positive pregnancy test, planning to become pregnant during screening, active treatment, or the follow up period, breastfeeding, or judged to be using inadequate contraceptive methods. * Subjects who underwent previous intra abdominal, GI tract surgery or a major abdominal trauma. * Subjects with other implanted electrical stimulation devices * Subjects with motility disorders of the GI tract such as gastroparesis * Subjects who are receiving medications known to affect gastric motility * Subjects with history of peptic ulcer disease * Subjects with any serious health condition, such as cancer, cardiac diseases, immunodeficiency disorders, liver disease, pulmonary disease, renal insufficiency, coagulopathy or a major depressive disorder. * Subjects with severe diabetic complications, such as retinopathy or nephropathy * Subjects with metabolic or endocrine disorders like primary or secondary Cushing syndrome * Subjects who received another investigational agent within 30 days prior to screening * Evidence of current or recent alcohol or drug abuse within the past year prior to screening * Subjects who are unlikely to be available for follow-up as specified in the protocol * Subjects with a past or present psychiatric condition that may impair his or her ability to comply with the study procedures * Subjects with history of volvulus * Subjects with history of known small bowel adhesions or any known GI adhesions * Subjects with deficiencies of known vitamins, e.g. B12 * Subjects with known celiac disease or inflammatory bowel disease * Subjects with conditions that, in the judgment of the investigator, precludes successful participation to the study.